Table 2 Clinical data among patients (n = 37)
Clinical data | No. (%) |
|---|---|
Preceding infection | |
No | 11 (29.7%) |
Gastrointestinal | 10 (27.0%) |
Respiratory | 16 (43.2%) |
Clinical presentation | |
Motor | 10 (27%) |
Motor and sensory | 27 (73%) |
Cranial nerve | |
No | 17 (45.9%) |
Facial | 7 (18.9%) |
Bulbar | 5 (13.5%) |
Facial and bulbar | 8 (21.6%) |
Autonomic symptoms | |
No | 29 (78.4%) |
Yes | 8 (21.6%) |
Hughes-Score (HS) at presentation and (on day 14) | |
HS 0 n = 0 (n = 0) HS 1 n = 2 (n = 1) HS 2 n = 4 (n = 2) HS 3 n = 10 (n = 14) HS 4 n = 21 (n = 20) | |
Guillain–Barré syndrome subtype | |
Demyelinating | 22 (59.5%) |
Axonal | 4 (10.8%) |
Mixed axonal and demyelinating | 11 (29.7%) |
Treatment | |
Intravenous immunoglobulins | 37 (100%) |
Plasmapheresis | 0 (0%) |